过去一年中添加的文章，按日期排序
Comparison of drug–drug interaction checking databases for interactions involving BCR-ABL tyrosine kinase inhibitors
A Günay, E Demirpolat, MB Yerer… - İstanbul Journal of …, 2024 - dergipark.org.tr
89 天前 - … DDIs of 100 drugs with six BCR-ABL TKIs—dasatinib, imatinib, nilotinib, ponatinib,
… Dasatinib, nilotinib, and bosutinib combinations with azole antifungals were listed as …
… Dasatinib, nilotinib, and bosutinib combinations with azole antifungals were listed as …
Efficacy of Frontline Treatment with Initial Low-Dose Tyrosine-Kinase Inhibitors in Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study
C Bucelli, I Capodanno, MC Miggiano, F Cavazzini… - Blood, 2023 - Elsevier
214 天前 - … Introduction Three TKIs, imatinib (IM), dasatinib (DAS) and nilotinib (NIL), are
approved … To avoid long term adverse events or potential drug interactions, elderly patients may …
approved … To avoid long term adverse events or potential drug interactions, elderly patients may …